Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Nystrand I"'
Autor:
Sorigue, M, Prusila, REI, Jauhiainen, J, Mercadal, S, Postila, A, Salmi, P, Tanhua, T, Tikkanen, S, Kakko, S, Kuitunen, H, Pollari, M, Nystrand, I, Kuusisto, MEL, Vasala, K, Jantunen, E, Korkeila, E, Karihtala, P, Sancho, JM, Turpeenniemi-Hujanen, T, Kuittinen, O
Publikováno v:
Acta Oncologica
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Introduction: Patients with follicular lymphoma (FL) have classically had a higher risk of solid cancers than the general population, but there is little data available in patients diagnosed and treated with modern day regimens. Material and methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::b1c81030f52a0793479d4c97ca5ac940
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2872
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2872
Autor:
Prusila, R. E. (Roosa E. I.), Sorigue, M. (Marc), Jauhiainen, J. (Jyrki), Mercadal, S. (Santiago), Postila, A. (Aleksi), Salmi, P. (Petteri), Tanhua, T. (Taru), Tikkanen, S. (Susanna), Kakko, S. (Sakari), Kuitunen, H. (Hanne), Pollari, M. (Marjukka), Nystrand, I. (Ilja), Kuusisto, M. E. (Milla E. L.), Vasala, K. (Kaija), Jantunen, E. (Esa), Korkeila, E. (Eija), Karihtala, P. (Peeter), Sancho, J. (Juan‐Manuel), Turpeenniemi‐Hujanen, T. (Taina), Kuittinen, O. (Outi)
Publikováno v:
British Journal of Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Follicular lymphoma (FL) is the most common indolent lymphoma. Currently there are many comparable treatment options available for FL. When selecting the most optimal therapy it is important to consider possible late effects of the treatment as well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::207fb7a1e225966ac134639fc2db5fd4
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3184
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3184
Autor:
Rajamäki A; Department of Oncology, Central Finland Central Hospital, Jyväskylä, Finland.; Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland., Sunela K; Department of Oncology, Tays Cancer Center, Tampere University Hospital, Tampere, Finland., Prusila REI; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland., Kuusisto MEL; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland.; Department of Haematology, Oulu University Hospital, Oulu, Finland., Mercadal S; ICO-Hospital Duran I Reynals, L'Hospitalet, Spain., Selander T; Science Service Center, Kuopio University Hospital, Kuopio, Finland., Kuitunen H; Department of Oncology, Oulu University Hospital, Oulu, Finland., Pollari M; Department of Oncology, Tays Cancer Center, Tampere University Hospital, Tampere, Finland., Jantunen E; Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland.; Department of Medicine, Kuopio University Hospital, Kuopio, Finland.; Department of Medicine, North Carelia Central Hospital, Joensuu, Finland., Nystrand I; Research Program Unit, Medical Faculty, University of Helsinki, Finland., Sancho JM; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Functional cytomics-IJC, Badalona, Spain., Sorigue M; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Functional cytomics-IJC, Badalona, Spain., Kuittinen O; Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland.; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland.; Department of Oncology, Kuopio University Hospital, Kuopio, Finland.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2021 Jul; Vol. 62 (7), pp. 1639-1647. Date of Electronic Publication: 2021 Feb 05.
Autor:
Enemark, Marie Hairing1,2 (AUTHOR) mariem@rm.dk, Hemmingsen, Jonas Klejs1 (AUTHOR) johemm@rm.dk, Jensen, Maja Lund1 (AUTHOR) majalj@rm.dk, Kridel, Robert3 (AUTHOR) robert.kridel@uhn.ca, Ludvigsen, Maja1,2 (AUTHOR) majlud@rm.dk
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11179. 52p.
Autor:
Sorigue M; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras, Barcelona, Spain., Prusila REI; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Jauhiainen J; Department of Applied Physics, University of Eastern Finland, Kuopio, Finland., Mercadal S; Department of Hematology, ICO-Hospital Duran i Reynals, Hospitalet de Llobregat, Spain., Postila A; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Salmi P; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Tanhua T; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Tikkanen S; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Kakko S; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Kuitunen H; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Pollari M; Department of Oncology, Tampere University Hospital, Tampere, Finland., Nystrand I; Department of Oncology, University of Turku and Turku University Hospital, Turku, Finland., Kuusisto MEL; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Siunsote - Hospital District of North Carelia, Joensuu, Finland., Vasala K; Department of Oncology and Radiotherapy, Central Finland Central Hospital, Jyvaskyla, Finland., Jantunen E; Siunsote - Hospital District of North Carelia, Joensuu, Finland.; Department of Medicine, Kuopio University Hospital, Kuopio, Finland.; Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland., Korkeila E; Department of Oncology, University of Turku and Turku University Hospital, Turku, Finland., Karihtala P; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Sancho JM; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras, Barcelona, Spain., Turpeenniemi-Hujanen T; Medical Research Center, Oulu University Hospital and Cancer and Translational Research Unit, University of Oulu, Oulu, Finland.; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Kuittinen O; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland.; Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland.; Department of Oncology, Kuopio University Hospital, Kuopio, Finland.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2019 Nov; Vol. 58 (11), pp. 1564-1569. Date of Electronic Publication: 2019 Aug 01.
Autor:
Prusila REI; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland., Sorigue M; Department of Haematology, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras, Badalona, Spain., Jauhiainen J; Department of Applied Physics, University of Eastern Finland, Kuopio, Finland., Mercadal S; Department of Haematology, ICO-Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona, Spain., Postila A; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland., Salmi P; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland., Tanhua T; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland., Tikkanen S; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland., Kakko S; Department of Haematology, Oulu University Hospital, Oulu, Finland., Kuitunen H; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland., Pollari M; Department of Oncology, Tampere University Hospital, Tampere, Finland., Nystrand I; Department of Oncology, Turku University Hospital, Turku, Finland., Kuusisto MEL; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland.; Siunsote - Hospital District of North Carelia, Joensuu, Finland., Vasala K; Department of Oncology and Radiotherapy, Central Finland Central Hospital, Jyväskylä, Finland., Jantunen E; Siunsote - Hospital District of North Carelia, Joensuu, Finland.; Department of Medicine, Kuopio University Hospital, Kuopio, Finland.; Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland., Korkeila E; Department of Oncology, Turku University Hospital, Turku, Finland., Karihtala P; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland., Sancho JM; Department of Haematology, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras, Badalona, Spain., Turpeenniemi-Hujanen T; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland., Kuittinen O; Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland.; Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland.; Department of Oncology, Kuopio University Hospital, Kuopio, Finland.
Publikováno v:
British journal of haematology [Br J Haematol] 2019 Nov; Vol. 187 (3), pp. 364-371. Date of Electronic Publication: 2019 Jul 03.
Autor:
Tsemach, Ehud1 ehudtsem@stanford.edu, Zohar, Anat2
Publikováno v:
Journal of Curriculum Studies. Feb2023, Vol. 55 Issue 1, p63-81. 19p. 2 Charts.
Autor:
Fiore, R. fiore@fis.unical.it, Jenkovszky, L.1 jenk@bitp.kiev.ua, Libov, V.2 vladyslav.libov@desy.de, Machado, M.3 magnus@if.ufrgs.br
Publikováno v:
Theoretical & Mathematical Physics. Jan2015, Vol. 182 Issue 1, p141-149. 9p.
Autor:
Şengül, M. Y.
Publikováno v:
International Journal of Modern Physics E: Nuclear Physics; Sep2017, Vol. 26 Issue 9, p-1, 10p
Publikováno v:
British Journal of Haematology; Feb1997, Vol. 96 Issue 2, p259-265, 7p